CoChat
Sign Up
Cited by 77

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains

Bai, Guang, Cheung, Iris, Shulha, Hennady P., Coelho, Joana E., Li, Ping, Dong, Xianjun, Jakovcevski, Mira, Wang, Yumei, Grigorenko, Anastasia, Jiang, Yan, Hoss, Andrew, Patel, Krupal, Zheng, Ming, Rogaev, Evgeny, Myers, Richard H., Weng, Zhiping, Akbarian, Schahram, Chen, Jiang-Fan·2015·Human Molecular Genetics
DOI 10.1093/hmg/ddu561
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddu561

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 76

  1. Martin, 1986, Huntington's disease. Pathogenesis and management, N. Engl. J. Med., 315, 1267, 10.1056/NEJM198611133152006 · DOI
  2. Vonsattel, 1998, Huntington disease, J. Neuropathol. Exp. Neurol., 57, 369, 10.1097/00005072-199805000-00001 · DOI
  3. Group, T.H.s.D.C.R., 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group, Cell, 72, 971, 10.1016/0092-8674(93)90585-E · DOI · Paper page
  4. MacDonald, 2003, Huntington's disease, Neuromol. Med., 4, 7, 10.1385/NMM:4:1-2:7 · DOI
  5. Gusella, 2009, Huntington's disease: the case for genetic modifiers, Genome Med., 1, 80, 10.1186/gm80 · DOI
  6. Djousse, 2003, Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease, Am. J. Med. Genet. A, 119A, 279, 10.1002/ajmg.a.20190 · DOI · Paper page
  7. Cha, 2000, Transcriptional dysregulation in Huntington's disease, Trends Neurosci., 23, 387, 10.1016/S0166-2236(00)01609-X · DOI
  8. Dunah, 2002, Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease, Science, 296, 2238, 10.1126/science.1072613 · DOI
  9. Vashishtha, 2013, Targeting H3K4 trimethylation in Huntington disease, Proc. Natl Acad. Sci. USA, 110, E3027, 10.1073/pnas.1311323110 · DOI
  10. Steffan, 2000, The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription, Proc. Natl Acad. Sci. USA, 97, 6763, 10.1073/pnas.100110097 · DOI
  11. Dompierre, 2007, Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation, J. Neurosci.: the Official Journal of the Society for Neuroscience, 27, 3571, 10.1523/JNEUROSCI.0037-07.2007 · DOI · Paper page
  12. Ferrante, 2003, Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice, J. Neurosci.: the Official Journal of the Society for Neuroscience, 23, 9418, 10.1523/JNEUROSCI.23-28-09418.2003 · DOI
  13. Ryu, 2003, Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway, Proc. Natl Acad. Sci. USA, 100, 4281, 10.1073/pnas.0737363100 · DOI
  14. Thomas, 2008, The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice, Proc. Natl Acad. Sci. USA, 105, 15564, 10.1073/pnas.0804249105 · DOI
  15. Goula, 2012, Transcription elongation and tissue-specific somatic CAG instability, PLoS Genet., 8, e1003051, 10.1371/journal.pgen.1003051 · DOI
  16. Sun, 2005, Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase, J. Biol. Chem., 280, 35261, 10.1074/jbc.M504012200 · DOI
  17. Seong, 2010, Huntingtin facilitates polycomb repressive complex 2, Hum. Mol. Genet., 19, 573, 10.1093/hmg/ddp524 · DOI
  18. Lee, 2012, ATRX induction by mutant huntingtin via Cdx2 modulates heterochromatin condensation and pathology in Huntington's disease, Cell Death Diff., 19, 1109, 10.1038/cdd.2011.196 · DOI
  19. Ryu, 2006, ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease, Proc. Natl Acad. Sci. USA, 103, 19176, 10.1073/pnas.0606373103 · DOI
  20. Li, 2007, The role of chromatin during transcription, Cell, 128, 707, 10.1016/j.cell.2007.01.015 · DOI
  21. Guttman, 2009, Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals, Nature, 458, 223, 10.1038/nature07672 · DOI · Paper page
  22. Pan, 2007, Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells, Cell. Stem Cell, 1, 299, 10.1016/j.stem.2007.08.003 · DOI · Paper page
  23. Han, 2010, Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features, J. Neurochem., 113, 1073, 10.1111/j.1471-4159.2010.06672.x · DOI
  24. Cheung, 2010, Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex, Proc. Natl Acad. Sci. USA, 107, 8824, 10.1073/pnas.1001702107 · DOI · Paper page
  25. Myers, 1991, Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus, J. Neuropathol. Exp. Neurol., 50, 729, 10.1097/00005072-199111000-00005 · DOI
  26. Hadzi, 2012, Assessment of cortical and striatal involvement in 523 Huntington disease brains, Neurology, 79, 1708, 10.1212/WNL.0b013e31826e9a5d · DOI · Paper page
  27. van Roon-Mom, 2006, Aggregate distribution in frontal and motor cortex in Huntington's disease brain, Neuroreport, 17, 667, 10.1097/00001756-200604240-00022 · DOI
  28. Shulha, 2012, Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons, Arch. Gen. Psychiatr., 69, 314, 10.1001/archgenpsychiatry.2011.151 · DOI · Paper page
  29. Thathiah, 2013, beta-arrestin 2 regulates Abeta generation and gamma-secretase activity in Alzheimer's disease, Nat. Med., 19, 43, 10.1038/nm.3023 · DOI
  30. Peachey, 2012, GPR179 is required for depolarizing bipolar cell function and is mutated in autosomal-recessive complete congenital stationary night blindness, Am. J. Hum. Genet., 90, 331, 10.1016/j.ajhg.2011.12.006 · DOI
  31. Rodriguez, 2013, Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-Tooth neuropathy, Pediatr. Nephrol., 28, 339, 10.1007/s00467-012-2299-1 · DOI
  32. Paciorkowski, 2013, Making sense of genetic heterogeneity: emergence of pathways in developmental brain disorders, Neurology, 80, 426, 10.1212/WNL.0b013e31827f101c · DOI
  33. Wood, 2010, TMEM106B is a susceptibility locus for Ftld, Nat. Rev. Neurology, 6, 184, 10.1038/nrneurol.2010.22 · DOI
  34. Finch, 2011, TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers, Neurology, 76, 467, 10.1212/WNL.0b013e31820a0e3b · DOI · Paper page
  35. Rutherford, 2012, TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease, Neurology, 79, 717, 10.1212/WNL.0b013e318264e3ac · DOI
  36. O'Keeffe, 2008, NGF-promoted axon growth and target innervation requires GITRL-GITR signaling, Nat. Neurosci., 11, 135, 10.1038/nn2034 · DOI
  37. Xu, 2004, TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis, J. Biol. Chem., 279, 17278, 10.1074/jbc.C400063200 · DOI
  38. El Yakoubi, 2012, Hes4 controls proliferative properties of neural stem cells during retinal ontogenesis, Stem Cells, 30, 2784, 10.1002/stem.1231 · DOI
  39. Rabadan, 2012, Jagged2 controls the generation of motor neuron and oligodendrocyte progenitors in the ventral spinal cord, Cell Death Diff., 19, 209, 10.1038/cdd.2011.84 · DOI
  40. Hodges, 2006, Regional and cellular gene expression changes in human Huntington's disease brain, Human Molecular Genet., 15, 965, 10.1093/hmg/ddl013 · DOI · Paper page
  41. Kageyama, 2008, Roles of Hes genes in neural development, Dev. Growth Diff., 50, S97
  42. Bertrand, 2002, Proneural genes and the specification of neural cell types, Nat. Rev. Neuroscience, 3, 517, 10.1038/nrn874 · DOI
  43. Jhas, 2006, Hes6 inhibits astrocyte differentiation and promotes neurogenesis through different mechanisms, J. Neurosci., 26, 11061, 10.1523/JNEUROSCI.1358-06.2006 · DOI
  44. Maunakea, 2010, Conserved role of intragenic DNA methylation in regulating alternative promoters, Nature, 466, 253, 10.1038/nature09165 · DOI · Paper page
  45. Casarosa, 1999, Mash1 regulates neurogenesis in the ventral telencephalon, Development, 126, 525, 10.1242/dev.126.3.525 · DOI
  46. Diguet, 2005, Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice, J. Neural. Transm., 112, 613, 10.1007/s00702-004-0206-z · DOI
  47. Ryman-Rasmussen, 2007, Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors, Neuropharmacology, 52, 562, 10.1016/j.neuropharm.2006.08.028 · DOI
  48. Katritch, 2013, Structure-function of the G protein-coupled receptor superfamily, Ann. Rev. Pharmacol. Toxicol., 53, 531, 10.1146/annurev-pharmtox-032112-135923 · DOI
  49. Rajagopal, 2010, Teaching old receptors new tricks: biasing seven-transmembrane receptors, Nat. Rev. Drug Discovery, 9, 373, 10.1038/nrd3024 · DOI
  50. Ooi, 2008, Chromatin switching and transcriptional regulation in disease, Biochem. Soc. Trans., 36, 599, 10.1042/BST0360599 · DOI
  51. Urdinguio, 2009, Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies, Lancet. Neurol., 8, 1056, 10.1016/S1474-4422(09)70262-5 · DOI
  52. Stack, 2007, Modulation of nucleosome dynamics in Huntington's disease, Hum. Mol. Genet., 16, 1164, 10.1093/hmg/ddm064 · DOI
  53. Eidelberg, 2011, Brain networks in Huntington disease, J. Clin. Invest., 121, 484, 10.1172/JCI45646 · DOI
  54. Tai, 2004, The human premotor cortex is ‘mirror’ only for biological actions, Curr. Biol., 14, 117, 10.1016/j.cub.2004.01.005 · DOI
  55. Brooks, 1991, Detection of preclinical Parkinson's disease with PET, Geriatrics, 46, 25
  56. Scherfler, 2004, Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism, Brain: J. Neurol., 127, 1332, 10.1093/brain/awh150 · DOI
  57. Pasini, 2008, Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2, Gene Dev., 22, 1345, 10.1101/gad.470008 · DOI
  58. Lilja, 2013, Like a rolling histone: epigenetic regulation of neural stem cells and brain development by factors controlling histone acetylation and methylation, Biochimica et Biophysica Acta, 1830, 2354, 10.1016/j.bbagen.2012.08.011 · DOI
  59. Audet, 2012, Restructuring G-protein- coupled receptor activation, Cell, 151, 14, 10.1016/j.cell.2012.09.003 · DOI
  60. Adams, 1993, What is hemimethylated DNA?, FEBS Lett., 320, 243, 10.1016/0014-5793(93)80595-L · DOI
  61. Gao, 2011, Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers, Biochem. Pharmacol., 82, 658, 10.1016/j.bcp.2011.06.017 · DOI
  62. Verzijl, 2011, Functional selectivity of adenosine receptor ligands, Purinergic Signal., 7, 171, 10.1007/s11302-011-9232-0 · DOI
  63. Gusella, 2006, Huntington's disease: seeing the pathogenic process through a genetic lens, Trend Biochem. Sci., 31, 533, 10.1016/j.tibs.2006.06.009 · DOI
  64. Cussac, 2002, Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking, Mol. Pharmacol., 62, 578, 10.1124/mol.62.3.578 · DOI
  65. Illingworth, 2008, A novel CpG island set identifies tissue-specific methylation at developmental gene loci, PLoS Biol., 6, e22, 10.1371/journal.pbio.0060022 · DOI
  66. Bird, 2002, DNA methylation patterns and epigenetic memory, Gene Dev., 16, 6, 10.1101/gad.947102 · DOI · Paper page
  67. Petretto, 2006, Heritability and tissue specificity of expression quantitative trait loci, PLoS Genet., 2, e172, 10.1371/journal.pgen.0020172 · DOI
  68. Akbarian, 2009, Epigenetic regulation in human brain-focus on histone lysine methylation, Biol. Psychiatr., 65, 198, 10.1016/j.biopsych.2008.08.015 · DOI
  69. Huang, 2006, Chromatin immunoprecipitation in postmortem brain, J. Neurosci. Method., 156, 284, 10.1016/j.jneumeth.2006.02.018 · DOI
  70. Jiang, 2008, Isolation of neuronal chromatin from brain tissue, BMC Neuroscience, 9, 42, 10.1186/1471-2202-9-42 · DOI · Paper page
  71. Matevossian, 2008, Neuronal nuclei isolation from human postmortem brain tissue, J. Visual Exp, 20, e914
  72. Zhu, 2010, ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data, BMC Bioinformatics, 11, 237, 10.1186/1471-2105-11-237 · DOI
  73. Holemon, 2007, MethylScreen: DNA methylation density monitoring using quantitative PCR, BioTechniques, 43, 683, 10.2144/000112597 · DOI
  74. Brooks, 1991, The clinical role of PET in cerebrovascular disease, Neurosurg. Rev., 14, 91, 10.1007/BF00313030 · DOI
  75. Bai, 1995, Functional analysis of the proximal 5′-flanking region of the N-methyl-D-aspartate receptor subunit gene, NMDAR1, J. Biol. Chem., 270, 7737, 10.1074/jbc.270.13.7737 · DOI
  76. Bai, 2007, Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain, Mol. Pain, 3, 15, 10.1186/1744-8069-3-15 · DOI

Cited by

Sorted by citations

Metadata

Authors
Bai, G., Cheung, I., Shulha, H. P., Coelho, J. E., Li, P., Dong, X., Jakovcevski, M., Wang, Y., Grigorenko, A., Jiang, Y., Hoss, A., Patel, K., Zheng, M., Rogaev, E., Myers, R. H., Weng, Z., Akbarian, S., & Chen, J.-F.
Venue
Human Molecular Genetics
Publisher
Oxford University Press (OUP)
Published
2014-12-05
Volume
24
Issue
5
Pages
1441-1456
ISSN
  • 1460-2083
  • 0964-6906
DOI
10.1093/hmg/ddu561
Cited by
77
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review